Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma
about
Regulation of adaptive immunity; the role of interleukin-10Recombinant human interleukin 10 for induction of remission in Crohn's diseaseFibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyInterferons, interferon-like cytokines, and their receptorsA network map of Interleukin-10 signaling pathwayEx vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.Gene transfer approaches for the treatment of inflammatory bowel disease.Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance.IL-10 and its related cytokines for treatment of inflammatory bowel disease.Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritisNovel biological strategies in inflammatory bowel diseases.Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.Interleukin-10 in viral diseases and cancer: exiting the labyrinth?Management of ulcerative colitis and Crohn's disease.PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia.Molecular targets in the treatment of alcoholic hepatitis.Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.How to modulate inflammatory cytokines in liver diseases.Immunopathogenesis of IBD: insufficient suppressor function in the gut?Probiotics: properties, examples, and specific applications.Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.Small molecule tyrosine kinase inhibitors for the treatment of intestinal inflammationIL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell FunctionKetamine attenuates osteoarthritis of the knee via modulation of inflammatory responses in a rabbit model.Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel diseasePEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDOInterleukin 10 Restores Gastric Emptying, Electrical Activity, and Interstitial Cells of Cajal Networks in Diabetic Mice.Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium.Future therapeutic approaches for inflammatory bowel diseases.Inflamed gut mucosa: downstream of interleukin-10.The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease.Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicity.Why interleukin-10 supplementation does not work in Crohn's disease patients.The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases.
P2860
Q21131215-824E909A-8594-420B-AEC1-3BD051135F71Q24236636-50177093-8E55-4339-BC5E-5A719B4E9A4EQ26801150-73B54E99-9C7D-45A0-9965-3C990B02CE4BQ28293630-D5F8C2C3-9C15-4815-9A5E-8784C73A4119Q28603589-67608557-E312-4413-A38A-C80140DEB515Q30660529-EC137876-06DD-44ED-9DF5-1B0EA02D47DBQ33611989-5F84742C-CCBC-46D7-8047-72AF41A153CEQ34579182-2C7B74A7-418C-4660-A2E8-9AC597F245B6Q35122162-35CD607E-18EC-45C8-BA45-26B92D42D6BCQ35161097-572FD69E-7470-46C0-BE96-2625AC22F67DQ35215742-5A43E640-B933-4963-8600-DBF9A0F836CAQ35678651-1F4C23BA-35F4-4EE8-A34A-8871E9DFD2E9Q35769069-1FDE93B7-992C-46C8-AE1D-439EF43E248AQ35787653-49DF030C-9761-4E9E-B47A-3C1108EF56B1Q35861249-01F3B1BA-58E9-4270-81B0-63A231AF9960Q35951835-8DEE2227-7A3E-4614-A825-99215E9905A8Q36004867-69DC3550-6388-4414-AB7D-702C751CFA46Q36051650-022C50B9-E5AA-4A6D-973C-3A8BD02ACE41Q36351877-BCC0E910-4FC7-4828-A52F-50759CAB5C09Q36439020-C75EFAE4-2B0B-4490-B9C5-1F8895B159A6Q36619707-67C5E2CD-E3B4-48CF-B6C4-084649041E75Q36626285-8A95C4FF-6E3F-4F4A-AE89-C4441FA0A700Q36629073-73262A10-6CAB-4090-B64E-9A70D66B3AB8Q36715205-44FD2FA8-1357-4CDE-A78F-DA6F90435788Q36855014-E4AEDD54-DF94-4387-A36E-B2E2D900C9BAQ36923849-B8ED9AD5-AB45-4673-983C-4A0B3D30B22DQ36931350-89EF10C8-92D9-4E5A-AA47-1A7E56469776Q37053638-0E8621D1-883D-4E6F-BA4D-10677A5BF572Q37222162-2AC00602-5484-45B6-866D-6B4DF2B0490DQ37297165-E141C166-F30E-477F-B689-670C9F6A1EB9Q37544674-7A989B7A-B290-4EDF-87AB-E9EB5E3B6890Q37713389-0EB3E7EC-107A-4031-8634-BD3A5C68D648Q37870435-7806C70C-9EB7-4507-A60D-104DD4AD7999Q37883443-976ECD94-248C-436A-9FDB-E0445E88FDB2Q38008355-DE002D65-2F4D-46B1-872B-81BD4B719DEDQ38034469-C5071A9B-1F4F-4DA5-87CB-03CF6FB265E8Q38105994-E99D6C72-69E3-4CB4-87DA-E6E77D52C5C7Q38120519-D88904AF-954F-464F-BEF7-75A47B122473Q38132555-DE630DF4-1F62-42D2-BAEA-7F034303372DQ38339037-877B8EBD-F6EC-4B47-B1F9-8316C06C64A1
P2860
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@ast
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@en
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@nl
type
label
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@ast
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@en
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@nl
prefLabel
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@ast
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@en
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@nl
P2093
P2860
P3181
P356
P1433
P1476
Treatment of Crohn's disease w ...... tory cytokine interferon gamma
@en
P2093
A van den Ende
C van Montfrans
J C Koningsberger
P2860
P3181
P356
10.1136/GUT.50.2.191
P407
P577
2002-02-01T00:00:00Z